Loading ...Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and the Juvenile Diabetes Research Foundation (JDRF) announced today a unique partnership to develop therapeutic treatments for people with type 1 diabetes at different stages of the disease — both those living with the disease and the newly diagnosed — as well as preventing diabetes in those at risk.
Popular
type 2 diabetes type 1 diabetes Diabetes Complications diabetes research diabetes management managing diabetes JDRF diabetes support american diabetes association Diabetes Community women's health obesity type 2 diabetes risk children's health type 2 diabetes prevention kids with diabetes diabetes type 2 diabetes treatment insulin diabetes treatment obesity epidemic insulin resistance juvenile diabetes children with diabetes Tanya Zuckerbrot